Related Experiment Video
Updated: May 13, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
Serologic vaccination response after solid organ transplantation: a systematic review
Isabella Eckerle1, Kerstin Daniela Rosenberger, Marcel Zwahlen
1Section of Clinical Tropical Medicine, Department of Infectious Diseases, University Hospital Heidelberg, Heidelberg, Germany. eckerle@virology-bonn.de
Vaccination response in solid organ transplant (SOT) recipients is often lower than in healthy individuals, with antibody levels declining rapidly for some vaccines. More research is urgently needed to improve infectious disease prevention in SOT patients.
Area of Science:
- Transplantation Medicine
- Immunology
- Vaccinology
Background:
- Infectious diseases are a major complication following solid organ transplantation (SOT).
- Vaccination is a desirable preventive strategy, but evidence on its efficacy in SOT recipients is inconsistent.
Purpose of the Study:
- To systematically review the serologic response rates to various post-transplantation vaccinations in SOT recipients.
- To assess the current evidence base for vaccination guidelines in SOT patients.
Main Methods:
- Systematic review of 72 studies identified from an initial search of 2478 papers.
- Analysis of serologic response rates to vaccines including tetanus, diphtheria, polio, hepatitis A and B, influenza, pneumococcal, meningococcal, and MMR.
Main Results:
- Most clinical trials were small, heterogeneous, and focused on specific SOT populations.
- SOT recipients generally exhibit a lower immune response to most vaccines compared to healthy controls.
- The impaired response varies by vaccine type, recipient age, and transplanted organ; antibody levels may decline rapidly.
Conclusions:
- Current vaccination strategies for SOT recipients are suboptimal and lack strong evidential support.
- Limited knowledge exists regarding vaccination responses in SOT recipients despite numerous studies.
- There is a critical need for large-scale, well-designed vaccination trials in defined SOT cohorts to inform evidence-based guidelines.
Related Concept Videos
Cell-mediated Immune Responses
Humoral Immune Responses
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Vaccinations
